BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 28868935)

  • 1. Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy.
    Bakogeorgos M; Georgoulias V
    Expert Rev Anticancer Ther; 2017 Nov; 17(11):1045-1060. PubMed ID: 28868935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives.
    Poupon L; Kerckhove N; Vein J; Lamoine S; Authier N; Busserolles J; Balayssac D
    Expert Opin Drug Saf; 2015 Aug; 14(8):1269-82. PubMed ID: 26058312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy-induced peripheral neuropathy].
    Noguchi E; Maeda Y
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1773-6. PubMed ID: 22083183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
    Amara S
    Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-induced neuropathy: A comprehensive survey.
    Miltenburg NC; Boogerd W
    Cancer Treat Rev; 2014 Aug; 40(7):872-82. PubMed ID: 24830939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updating your peripheral neuropathy "know-how".
    Marrs J; Newton S
    Clin J Oncol Nurs; 2003; 7(3):299-303. PubMed ID: 12793336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
    Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
    Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives.
    Ewertz M; Qvortrup C; Eckhoff L
    Acta Oncol; 2015 May; 54(5):587-91. PubMed ID: 25751757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nursing care of chemotherapy-induced peripheral neuropathy].
    Hsu SY; Lu CH; Chen SZ; Jane SW
    Hu Li Za Zhi; 2015 Apr; 62(2):84-8. PubMed ID: 25854951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy-induced peripheral neuropathy; impact on quality of life].
    Scheel A; Beijers AJ; Mols F; Faber CG; Vreugdenhil G
    Ned Tijdschr Geneeskd; 2014; 158():A7455. PubMed ID: 25315326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview.
    Chan A; Hertz DL; Morales M; Adams EJ; Gordon S; Tan CJ; Staff NP; Kamath J; Oh J; Shinde S; Pon D; Dixit N; D'Olimpio J; Dumitrescu C; Gobbo M; Kober K; Mayo S; Pang L; Subbiah I; Beutler AS; Peters KB; Loprinzi C; Lustberg MB
    Support Care Cancer; 2019 Oct; 27(10):3729-3737. PubMed ID: 31363906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy: a short review.
    De Grandis D
    CNS Drugs; 2007; 21 Suppl 1():39-43; discussion 45-6. PubMed ID: 17696592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy-Induced Peripheral Neuropathy: Causative Agents, Preventative Strategies, and Treatment Approaches.
    Kachrani R; Santana A; Rogala B; Pawasauskas J
    J Pain Palliat Care Pharmacother; 2020 Sep; 34(3):141-152. PubMed ID: 32118502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
    Kuriyama A; Endo K
    Support Care Cancer; 2018 Apr; 26(4):1051-1059. PubMed ID: 29280005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peripheral neuropathy as a side effect of chemotherapy and targeted therapy].
    Gießen-Jung C; von Baumgarten L
    Dtsch Med Wochenschr; 2018 Jul; 113(13):970-978. PubMed ID: 29972842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review.
    Schloss JM; Colosimo M; Airey C; Masci PP; Linnane AW; Vitetta L
    Clin Nutr; 2013 Dec; 32(6):888-93. PubMed ID: 23647723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review.
    Schloss J; Colosimo M; Vitetta L
    Crit Rev Food Sci Nutr; 2017 Apr; 57(6):1107-1118. PubMed ID: 25849070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-Induced Peripheral Neuropathy: Association With Increased Risk of Falls and Injuries.
    Autissier E
    Clin J Oncol Nurs; 2019 Aug; 23(4):405-410. PubMed ID: 31322611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP.
    Streckmann F; Balke M; Lehmann HC; Rustler V; Koliamitra C; Elter T; Hallek M; Leitzmann M; Steinmetz T; Heinen P; Baumann FT; Bloch W
    BMC Cancer; 2018 Jan; 18(1):62. PubMed ID: 29316888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of chemotherapy-induced peripheral neuropathy: A review of recent findings.
    Ibrahim EY; Ehrlich BE
    Crit Rev Oncol Hematol; 2020 Jan; 145():102831. PubMed ID: 31783290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.